Hudock, Inc. Astrazeneca PLC Transaction History

Hudock, Inc.

$578 Million
Q3 2024

A detailed history of Hudock, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Hudock, Inc. holds 3,603 shares of AZN stock, worth $241,437. This represents 0.05% of its overall portfolio holdings.

Number of Shares

3,603

Previous 3,603 -0.0%

Holding current value

$241,437

Previous $280,000 -0.0%

% of portfolio

0.05%

Previous 0.05%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	BUY	$66.81 - $80.83 $26,724 - $32,332	400 Added 12.49%	3,603 $280,000
Q1 2024 May 02, 2024	SELL	$61.03 - $69.57 $30,026 - $34,228	-492 Reduced 13.32%	3,203 $217,000
Q3 2023 Nov 06, 2023	SELL	$64.85 - $71.7 $16,212 - $17,925	-250 Reduced 6.34%	3,695 $250,000
Q2 2023 Jul 31, 2023	BUY	$69.91 - $75.81 $39,778 - $43,135	569 Added 16.85%	3,945 $282,000
Q1 2023 May 08, 2023	SELL	$63.15 - $71.6 $18,945 - $21,480	-300 Reduced 8.16%	3,376 $234,000
Q4 2022 Feb 08, 2023	SELL	$54.21 - $70.44 $4,662 - $6,057	-86 Reduced 2.29%	3,676 $249,000
Q3 2022 Nov 02, 2022	BUY	$53.02 - $135.75 $159 - $407	3 Added 0.08%	3,762 $206,000
Q1 2022 May 02, 2022	BUY	$55.72 - $67.12 $222 - $268	4 Added 0.11%	3,759 $249,000
Q3 2021 Nov 09, 2021	BUY	$55.56 - $60.79 $21,612 - $23,647	389 Added 11.56%	3,755 $225,000
Q1 2021 Apr 26, 2021	SELL	$47.16 - $54.44 $29,805 - $34,406	-632 Reduced 15.81%	3,366 $167,000
Q4 2020 Feb 05, 2021	SELL	$48.52 - $58.02 $30,276 - $36,204	-624 Reduced 13.5%	3,998 $199,000
Q3 2020 Oct 23, 2020	BUY	$53.07 - $61.1 $53 - $61	1 Added 0.02%	4,622 $253,000
Q2 2020 Aug 11, 2020	BUY	$43.1 - $55.31 $54,435 - $69,856	1,263 Added 37.61%	4,621 $244,000
Q1 2020 Apr 27, 2020	BUY	$37.79 - $51.33 $75 - $102	2 Added 0.06%	3,358 $149,000
Q3 2019 Oct 31, 2019	BUY	$40.12 - $45.47 $80 - $90	2 Added 0.06%	3,356 $149,000
Q2 2019 Jul 30, 2019	SELL	$37.28 - $41.68 $74,560 - $83,360	-2,000 Reduced 37.36%	3,354 $138,000
Q1 2019 Apr 23, 2019	SELL	$35.49 - $43.02 $8,624 - $10,453	-243 Reduced 4.34%	5,354 $216,000
Q4 2018 Jan 29, 2019	SELL	$36.86 - $41.49 $18,356 - $20,662	-498 Reduced 8.17%	5,597 $211,000
Q3 2018 Oct 16, 2018	BUY	$34.76 - $39.72 $104 - $119	3 Added 0.05%	6,095 $241,000
Q1 2018 Apr 27, 2018	SELL	$32.97 - $36.63 $20,540 - $22,820	-623 Reduced 9.28%	6,092 $213,000
Q3 2017 Oct 27, 2017	SELL	$28.96 - $34.0 $1,679 - $1,972	-58 Reduced 0.86%	6,715 $227,000
Q2 2017 Aug 08, 2017	BUY	N/A	6,773	6,773 $230,000

Others Institutions Holding AZN

# of Institutions

1,360

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $208B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudock, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hudock, Inc. with notifications on news.

Account